DE69941083D1 - 12,13-cyclopropan-epothilonderivate - Google Patents
12,13-cyclopropan-epothilonderivateInfo
- Publication number
- DE69941083D1 DE69941083D1 DE69941083T DE69941083T DE69941083D1 DE 69941083 D1 DE69941083 D1 DE 69941083D1 DE 69941083 T DE69941083 T DE 69941083T DE 69941083 T DE69941083 T DE 69941083T DE 69941083 D1 DE69941083 D1 DE 69941083D1
- Authority
- DE
- Germany
- Prior art keywords
- epothilonderivate
- cyclopropan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8256498P | 1998-04-21 | 1998-04-21 | |
PCT/US1999/007448 WO1999054318A1 (en) | 1998-04-21 | 1999-04-05 | 12,13-cyclopropane epothilone derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69941083D1 true DE69941083D1 (en) | 2009-08-20 |
Family
ID=22171978
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69941083T Expired - Lifetime DE69941083D1 (en) | 1998-04-21 | 1999-04-05 | 12,13-cyclopropan-epothilonderivate |
DE69933287T Expired - Lifetime DE69933287T2 (de) | 1998-04-21 | 1999-04-05 | 12,13-modifizierte epothilon-derivate |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69933287T Expired - Lifetime DE69933287T2 (de) | 1998-04-21 | 1999-04-05 | 12,13-modifizierte epothilon-derivate |
Country Status (17)
Country | Link |
---|---|
US (2) | US6380395B1 (de) |
EP (3) | EP1073648B1 (de) |
JP (2) | JP2002512238A (de) |
CN (1) | CN1142923C (de) |
AR (2) | AR015007A1 (de) |
AT (2) | ATE435861T1 (de) |
AU (2) | AU757733B2 (de) |
BR (1) | BR9909795A (de) |
CA (2) | CA2329181C (de) |
CY (2) | CY1105836T1 (de) |
DE (2) | DE69941083D1 (de) |
DK (3) | DK1073647T3 (de) |
ES (3) | ES2400049T3 (de) |
PE (1) | PE20000460A1 (de) |
PT (3) | PT1589017E (de) |
TR (1) | TR200003036T2 (de) |
WO (2) | WO1999054319A1 (de) |
Families Citing this family (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050043376A1 (en) * | 1996-12-03 | 2005-02-24 | Danishefsky Samuel J. | Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
EP0977563B1 (de) | 1996-12-03 | 2005-10-12 | Sloan-Kettering Institute For Cancer Research | Synthese von epothilonen, zwischenprodukte dazu, analoga und verwendungen davon |
US6204388B1 (en) * | 1996-12-03 | 2001-03-20 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
GB9810659D0 (en) | 1998-05-18 | 1998-07-15 | Ciba Geigy Ag | Organic compounds |
DE19826988A1 (de) | 1998-06-18 | 1999-12-23 | Biotechnolog Forschung Gmbh | Epothilon-Nebenkomponenten |
US6410301B1 (en) | 1998-11-20 | 2002-06-25 | Kosan Biosciences, Inc. | Myxococcus host cells for the production of epothilones |
US6303342B1 (en) | 1998-11-20 | 2001-10-16 | Kason Biosciences, Inc. | Recombinant methods and materials for producing epothilones C and D |
JP2002531396A (ja) * | 1998-12-02 | 2002-09-24 | ファイザー・プロダクツ・インク | p53ファミリーのタンパク質の配座安定性を回復するための方法及び組成物 |
US6780620B1 (en) * | 1998-12-23 | 2004-08-24 | Bristol-Myers Squibb Company | Microbial transformation method for the preparation of an epothilone |
US20020058286A1 (en) * | 1999-02-24 | 2002-05-16 | Danishefsky Samuel J. | Synthesis of epothilones, intermediates thereto and analogues thereof |
IL144590A0 (en) * | 1999-03-29 | 2002-05-23 | Bristol Myers Squibb Co | A process for the preparation of epothilone derivatives |
ID30460A (id) | 1999-04-15 | 2001-12-06 | Bristol Myers Squibb Co | Inhibitor-inhibitor protein siklik tirosin kinase |
US7125875B2 (en) | 1999-04-15 | 2006-10-24 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
US6593115B2 (en) * | 2000-03-24 | 2003-07-15 | Bristol-Myers Squibb Co. | Preparation of epothilone intermediates |
US6989450B2 (en) | 2000-10-13 | 2006-01-24 | The University Of Mississippi | Synthesis of epothilones and related analogs |
SK8552003A3 (en) * | 2001-01-25 | 2004-06-08 | Bristol Myers Squibb Co | Parenteral formulation containing epothilone analogs |
IL156578A0 (en) * | 2001-01-25 | 2004-01-04 | Bristol Myers Squibb Co | A method for formulating an epothilone analog for pharmaceutical use and pharmaceutical preparations including an epothilone analog |
WO2002058699A1 (en) | 2001-01-25 | 2002-08-01 | Bristol-Myers Squibb Company | Pharmaceutical forms of epothilones for oral administration |
PT1353668E (pt) | 2001-01-25 | 2008-06-30 | Bristol Myers Squibb Co | Processos de preparação de substâncias farmacêutica contendo substâncias análogas à epotilona para o tratamento de cancro |
WO2002066038A1 (en) | 2001-02-20 | 2002-08-29 | Bristol-Myers Squibb Company | Treatment of refractory tumors using epothilone derivatives |
EP1368030A1 (de) | 2001-02-20 | 2003-12-10 | Bristol-Myers Squibb Company | Epothilon-derivative zur behandlung von refraktären tumoren |
SK11082003A3 (sk) * | 2001-03-14 | 2004-08-03 | Bristol-Myers Squibb Company | Kombinácia analógov epotilónu a chemoterapeutických činidiel na liečenie proliferatívnych ochorení |
EP1389209B1 (de) * | 2001-04-24 | 2009-04-08 | Purdue Research Foundation | Folat-mimetika und deren folatrezeptorbindende konjugate |
MXPA03010909A (es) | 2001-06-01 | 2004-02-17 | Bristol Myers Squibb Co | Derivados de epotilona. |
CA2456280A1 (en) * | 2001-08-23 | 2003-03-06 | Novartis Ag | Cyclopropyl and cyclobutyl epothilone analogs |
WO2003026744A1 (en) * | 2001-09-25 | 2003-04-03 | Alcon, Inc. | The use of epothilones and analogs in conjunction with ophthalmic surgery |
TW200303202A (en) * | 2002-02-15 | 2003-09-01 | Bristol Myers Squibb Co | Method of preparation of 21-amino epothilone derivatives |
AU2003218107A1 (en) * | 2002-03-12 | 2003-09-29 | Bristol-Myers Squibb Company | C12-cyano epothilone derivatives |
EP1483251B1 (de) | 2002-03-12 | 2009-12-23 | Bristol-Myers Squibb Company | C3-cyanoepothilonderivate |
TW200403994A (en) | 2002-04-04 | 2004-03-16 | Bristol Myers Squibb Co | Oral administration of EPOTHILONES |
TW200400191A (en) | 2002-05-15 | 2004-01-01 | Bristol Myers Squibb Co | Pharmaceutical compositions and methods of using C-21 modified epothilone derivatives |
US7910594B2 (en) * | 2002-05-15 | 2011-03-22 | Endocyte, Inc. | Vitamin-mitomycin conjugates |
US7405234B2 (en) | 2002-05-17 | 2008-07-29 | Bristol-Myers Squibb Company | Bicyclic modulators of androgen receptor function |
AU2003243561A1 (en) * | 2002-06-14 | 2003-12-31 | Bristol-Myers Squibb Company | Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
CN1671856B (zh) * | 2002-07-31 | 2010-05-12 | 卫材R&D管理株式会社 | 生理活性物质 |
ATE381569T1 (de) * | 2002-08-02 | 2008-01-15 | Novartis Pharma Gmbh | Epothilonderivate |
US6921769B2 (en) | 2002-08-23 | 2005-07-26 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
US7649006B2 (en) * | 2002-08-23 | 2010-01-19 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
EP1767535B1 (de) * | 2002-08-23 | 2009-12-02 | Sloan-Kettering Institute For Cancer Research | Synthese von Epothilonen, Zwischenprodukte davon, Analoga und ihre Verwendung |
KR101406635B1 (ko) | 2002-09-23 | 2014-06-11 | 브리스톨-마이어스 스큅 컴퍼니 | 에포틸론 b의 제조, 분리 및 정제 방법, 및 에포틸론 b의 x-선 결정 구조 |
JP2006504743A (ja) * | 2002-10-09 | 2006-02-09 | コーザン バイオサイエンシス インコーポレイテッド | 治療製剤 |
JP2006504727A (ja) * | 2002-10-11 | 2006-02-09 | ダナ−ファーバー キャンサー インスティテュート,インコーポレイテッド | 多発性骨髄腫の処置のためのラクトン誘導体 |
EP1567487A4 (de) | 2002-11-15 | 2005-11-16 | Bristol Myers Squibb Co | Offenkettige, mit prolylharnstoff verwandtemodulatoren der androgenrezeptorfunktion |
EP2517730A3 (de) | 2003-01-27 | 2013-01-02 | Endocyte, Inc. | Vitaminrezeptorbindende Wirkstofffreisetzungskonjugate |
CN1867343A (zh) * | 2003-10-09 | 2006-11-22 | 高山生物科学股份有限公司 | 治疗制剂 |
EP1670487A4 (de) * | 2003-10-09 | 2008-05-21 | Kosan Biosciences Inc | Therapeutische formulierungen |
US20050171167A1 (en) * | 2003-11-04 | 2005-08-04 | Haby Thomas A. | Process and formulation containing epothilones and analogs thereof |
US7820702B2 (en) | 2004-02-04 | 2010-10-26 | Bristol-Myers Squibb Company | Sulfonylpyrrolidine modulators of androgen receptor function and method |
US7378426B2 (en) | 2004-03-01 | 2008-05-27 | Bristol-Myers Squibb Company | Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3 |
US7625923B2 (en) | 2004-03-04 | 2009-12-01 | Bristol-Myers Squibb Company | Bicyclic modulators of androgen receptor function |
US7696241B2 (en) | 2004-03-04 | 2010-04-13 | Bristol-Myers Squibb Company | Bicyclic compounds as modulators of androgen receptor function and method |
CN101098854B (zh) | 2004-07-23 | 2012-12-05 | 恩多塞特公司 | 二价连接体及其轭合物 |
US10675326B2 (en) | 2004-10-07 | 2020-06-09 | The Board Of Trustees Of The University Of Illinois | Compositions comprising cupredoxins for treating cancer |
EP1824458A1 (de) * | 2004-11-18 | 2007-08-29 | Bristol-Myers Squibb Company | Kügelchen mit magensaftresistentem überzug mit epothilon oder einem epothilon-analogon und seine herstellung und verabreichung |
RU2349319C1 (ru) * | 2004-11-18 | 2009-03-20 | Бристол-Маерс Сквибб Компани | Гранула, покрытая энтеросолюбильной оболочкой, содержащая иксабепилон, и способ ее приготовления |
EP2634252B1 (de) | 2005-02-11 | 2018-12-19 | University of Southern California | Verfahren zur Expression von Proteinen mit Disulfidbrücken |
CN101175757B (zh) | 2005-03-16 | 2012-11-14 | 恩多塞特公司 | 蝶酸及其缀合物的合成和纯化 |
US7772177B2 (en) | 2005-05-18 | 2010-08-10 | Aegera Therapeutics, Inc. | BIR domain binding compounds |
CN103893779A (zh) * | 2005-08-19 | 2014-07-02 | 恩多塞特公司 | 多药物配体缀合物 |
EP1948240A2 (de) * | 2005-08-19 | 2008-07-30 | Endocyte, Inc. | Liganden-konjugate von vinca-alkaloiden, analoga und derivaten |
EP2029156A4 (de) | 2006-05-01 | 2010-07-21 | Univ Southern California | Kombinationstherapie zur krebsbehandlung |
JP5419685B2 (ja) | 2006-05-16 | 2014-02-19 | ファーマサイエンス・インコーポレイテッド | Iapbirドメイン結合タンパク質 |
AR061181A1 (es) * | 2006-05-25 | 2008-08-13 | Bristol Myers Squibb Co | Compuestos de aziridinil-epotilona |
PE20080102A1 (es) * | 2006-05-25 | 2008-02-11 | Bristol Myers Squibb Co | Conjugados de analogos de aziridinil-epotilona y composiciones farmaceuticas que comprenden los mismos |
AU2007329375A1 (en) | 2006-12-04 | 2008-06-12 | The Board Of Trustees Of The University Of Illinois | Compositions and methods to treat cancer with cupredoxins and CpG rich DNA |
AU2008212788A1 (en) | 2007-02-08 | 2008-08-14 | The Board Of Trustees Of The University Of Illinois | Compositions and methods to prevent cancer with cupredoxins |
WO2008101231A2 (en) * | 2007-02-16 | 2008-08-21 | Endocyte, Inc. | Methods and compositions for treating and diagnosing kidney disease |
AU2008224988A1 (en) * | 2007-03-14 | 2008-09-18 | Endocyte, Inc. | Binding ligand linked drug delivery conjugates of tubulysins |
EP2152717A1 (de) | 2007-05-25 | 2010-02-17 | Bristol-Myers Squibb Company | Verfahren zur herstellung von epothilonverbindungen und analoga |
US9877965B2 (en) | 2007-06-25 | 2018-01-30 | Endocyte, Inc. | Vitamin receptor drug delivery conjugates for treating inflammation |
AU2008268432B2 (en) * | 2007-06-25 | 2015-01-15 | Endocyte, Inc. | Conjugates containing hydrophilic spacer linkers |
WO2009055562A1 (en) | 2007-10-25 | 2009-04-30 | Endocyte, Inc. | Tubulysins and processes for preparing |
WO2009146152A2 (en) * | 2008-04-04 | 2009-12-03 | Emory University | Non-myelosuppressive compounds, pharmaceutical compositions thereof, and methods of treatment |
DK2276485T3 (da) * | 2008-04-24 | 2014-10-13 | Bristol Myers Squibb Co | Anvendelse af epothilon d i behandling af tau-associerede sygdomme,herunder alzheimers sygdom |
WO2010056901A2 (en) | 2008-11-13 | 2010-05-20 | University Of Southern California | Method of expressing proteins with disulfide bridges with enhanced yields and activity |
BR112012020113A2 (pt) | 2010-02-12 | 2016-06-07 | Pharmascience Inc | compostos de ligação ao domínio iap bir |
EP2571525A4 (de) | 2010-05-18 | 2016-04-27 | Cerulean Pharma Inc | Zusammensetzungen und verfahren zur behandlung von autoimmun- und anderen erkrankungen |
MX356514B (es) | 2011-01-20 | 2018-05-30 | Univ Texas | Marcadores de formación de imagen por resonancia magnética, sistemas de suministro y extracción, y métodos de fabricación y uso de los mismos. |
CN102863474A (zh) | 2011-07-09 | 2013-01-09 | 陈小平 | 一类治疗细胞增殖性疾病的铂化合物、其制备方法和应用 |
CN102993239A (zh) | 2011-09-19 | 2013-03-27 | 陈小平 | 离去基团含氨基或烷胺基的丁二酸衍生物的铂类化合物 |
US10080805B2 (en) | 2012-02-24 | 2018-09-25 | Purdue Research Foundation | Cholecystokinin B receptor targeting for imaging and therapy |
US20140080175A1 (en) | 2012-03-29 | 2014-03-20 | Endocyte, Inc. | Processes for preparing tubulysin derivatives and conjugates thereof |
SG11201502896XA (en) | 2012-10-16 | 2015-05-28 | Endocyte Inc | Drug delivery conjugates containing unnatural amino acids and methods for using |
CN104768962B (zh) | 2012-11-17 | 2017-04-05 | 北京市丰硕维康技术开发有限责任公司 | 离去基团是含氨基或烷氨基的丙二酸衍生物的铂类化合物 |
CA3002027A1 (en) | 2015-10-16 | 2017-04-20 | William Marsh Rice University | Epothilone analogs, methods of synthesis, methods of treatment, and drug conjugates thereof |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4138042C2 (de) | 1991-11-19 | 1993-10-14 | Biotechnolog Forschung Gmbh | Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel |
DE19639456A1 (de) | 1996-09-25 | 1998-03-26 | Biotechnolog Forschung Gmbh | Epothilon-Derivate, Herstellung und Mittel |
DK1186606T4 (da) | 1995-11-17 | 2011-12-05 | Biotechnolog Forschung Gmbh | Epothilonderivater, deres fremstilling og anvendelse |
DE19542986A1 (de) | 1995-11-17 | 1997-05-22 | Biotechnolog Forschung Gmbh | Epothilon-Derivate und deren Verwendung |
NZ334821A (en) | 1996-08-30 | 2000-12-22 | Novartis Ag | Method for producing epothilones |
DE19645361A1 (de) | 1996-08-30 | 1998-04-30 | Ciba Geigy Ag | Zwischenprodukte innerhalb der Totalsynthese von Epothilon A und B, Teil II |
DE19645362A1 (de) | 1996-10-28 | 1998-04-30 | Ciba Geigy Ag | Verfahren zur Herstellung von Epothilon A und B und Derivaten |
KR100538095B1 (ko) | 1996-11-18 | 2005-12-21 | 게젤샤프트 퓌어 비오테크놀로기쉐 포르슝 엠베하(게베에프) | 에포틸론 씨, 디, 이 및 에프, 그 제조방법 및 세포증식 억제제와 식물 위생제로서의 이들의 용도 |
US6515016B2 (en) | 1996-12-02 | 2003-02-04 | Angiotech Pharmaceuticals, Inc. | Composition and methods of paclitaxel for treating psoriasis |
EP0977563B1 (de) | 1996-12-03 | 2005-10-12 | Sloan-Kettering Institute For Cancer Research | Synthese von epothilonen, zwischenprodukte dazu, analoga und verwendungen davon |
US6204388B1 (en) | 1996-12-03 | 2001-03-20 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
US6380394B1 (en) | 1996-12-13 | 2002-04-30 | The Scripps Research Institute | Epothilone analogs |
US6441186B1 (en) | 1996-12-13 | 2002-08-27 | The Scripps Research Institute | Epothilone analogs |
DE19701758A1 (de) | 1997-01-20 | 1998-07-23 | Wessjohann Ludgar A Dr | Epothilone-Synthesebausteine |
KR100494179B1 (ko) | 1997-02-25 | 2005-06-10 | 게젤샤프트 퓌어 비오테크놀로기쉐 포르슝 엠베하(게베에프) | 변환된 측쇄를 가진 에포틸론 |
DE19713970B4 (de) | 1997-04-04 | 2006-08-31 | R&D-Biopharmaceuticals Gmbh | Epothilone-Synthesebausteine II - Prenylderivate |
ATE225783T1 (de) | 1997-04-18 | 2002-10-15 | Studiengesellschaft Kohle Mbh | Selektive olefinmetathese von bi- oder polyfunktionellen substraten in komprimiertem kohlendioxid als reaktionsmedium |
DE19821954A1 (de) | 1997-05-15 | 1998-11-19 | Biotechnolog Forschung Gmbh | Verfahren zur Herstellung eines Epothilon-Derivats |
DE19720312A1 (de) | 1997-05-15 | 1998-11-19 | Hoechst Ag | Zubereitung mit erhöhter in vivo Verträglichkeit |
DE19726627A1 (de) | 1997-06-17 | 1998-12-24 | Schering Ag | Zwischenprodukte, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Epothilon |
US6605599B1 (en) * | 1997-07-08 | 2003-08-12 | Bristol-Myers Squibb Company | Epothilone derivatives |
DE59805727D1 (de) | 1997-07-16 | 2002-10-31 | Schering Ag | Thiazolderivate, verfahren zur herstellung und verwendung |
EP1847540A1 (de) | 1997-08-09 | 2007-10-24 | Bayer Schering Pharma Aktiengesellschaft | Neue Epothilonderivate, Herstellungsverfahren dafür und ihre pharmazeutische Verwendung |
MY125921A (en) | 1998-02-05 | 2006-08-30 | Novartis Ag | Compositions containing organic compounds |
US6194181B1 (en) | 1998-02-19 | 2001-02-27 | Novartis Ag | Fermentative preparation process for and crystal forms of cytostatics |
FR2775187B1 (fr) | 1998-02-25 | 2003-02-21 | Novartis Ag | Utilisation de l'epothilone b pour la fabrication d'une preparation pharmaceutique antiproliferative et d'une composition comprenant l'epothilone b comme agent antiproliferatif in vivo |
DE69927790T2 (de) | 1998-02-25 | 2006-07-20 | Sloan-Kettering Institute For Cancer Research | Synthese von epothilonen, ihren zwischenprodukten und analogen verbindungen |
WO2000000485A1 (de) | 1998-06-30 | 2000-01-06 | Schering Aktiengesellschaft | Epothilon-derivate, verfahren zu deren herstellung, zwischenprodukte und ihre pharmazeutische verwendung |
US6303342B1 (en) | 1998-11-20 | 2001-10-16 | Kason Biosciences, Inc. | Recombinant methods and materials for producing epothilones C and D |
CA2352505C (en) | 1998-12-22 | 2009-04-07 | Novartis Ag | Epothilone derivatives and their use as antitumor agents |
EA009206B1 (ru) | 1999-02-18 | 2007-12-28 | Шеринг Акциенгезельшафт | Производные 16-галогенэпотилона и их фармацевтическое использование |
US6211412B1 (en) | 1999-03-29 | 2001-04-03 | The University Of Kansas | Synthesis of epothilones |
AR023792A1 (es) | 1999-04-30 | 2002-09-04 | Bayer Schering Pharma Ag | Derivados 6-alquenilo- y 6-alquinilo-epotilona, los procedimientos para prepararlos y su empleo en productos farmaceuticos |
-
1999
- 1999-03-29 US US09/280,192 patent/US6380395B1/en not_active Expired - Lifetime
- 1999-03-29 US US09/280,191 patent/US6399638B1/en not_active Expired - Lifetime
- 1999-04-05 TR TR2000/03036T patent/TR200003036T2/xx unknown
- 1999-04-05 ES ES05015236T patent/ES2400049T3/es not_active Expired - Lifetime
- 1999-04-05 WO PCT/US1999/007475 patent/WO1999054319A1/en active IP Right Grant
- 1999-04-05 DE DE69941083T patent/DE69941083D1/de not_active Expired - Lifetime
- 1999-04-05 DK DK99915273T patent/DK1073647T3/da active
- 1999-04-05 JP JP2000544657A patent/JP2002512238A/ja active Pending
- 1999-04-05 ES ES99915273T patent/ES2327803T3/es not_active Expired - Lifetime
- 1999-04-05 JP JP2000544658A patent/JP4476483B2/ja not_active Expired - Fee Related
- 1999-04-05 ES ES99916383T patent/ES2273484T3/es not_active Expired - Lifetime
- 1999-04-05 PT PT50152362T patent/PT1589017E/pt unknown
- 1999-04-05 DK DK05015236.2T patent/DK1589017T3/da active
- 1999-04-05 AU AU33827/99A patent/AU757733B2/en not_active Ceased
- 1999-04-05 AT AT99915273T patent/ATE435861T1/de active
- 1999-04-05 AT AT99916383T patent/ATE340177T1/de active
- 1999-04-05 PT PT99915273T patent/PT1073647E/pt unknown
- 1999-04-05 CN CNB998052663A patent/CN1142923C/zh not_active Expired - Fee Related
- 1999-04-05 CA CA2329181A patent/CA2329181C/en not_active Expired - Fee Related
- 1999-04-05 WO PCT/US1999/007448 patent/WO1999054318A1/en active IP Right Grant
- 1999-04-05 EP EP99916383A patent/EP1073648B1/de not_active Expired - Lifetime
- 1999-04-05 DE DE69933287T patent/DE69933287T2/de not_active Expired - Lifetime
- 1999-04-05 AU AU34716/99A patent/AU748526B2/en not_active Ceased
- 1999-04-05 PT PT99916383T patent/PT1073648E/pt unknown
- 1999-04-05 EP EP99915273A patent/EP1073647B1/de not_active Expired - Lifetime
- 1999-04-05 EP EP05015236A patent/EP1589017B1/de not_active Expired - Lifetime
- 1999-04-05 CA CA002323609A patent/CA2323609A1/en not_active Abandoned
- 1999-04-05 BR BR9909795-8A patent/BR9909795A/pt not_active IP Right Cessation
- 1999-04-05 DK DK99916383T patent/DK1073648T3/da active
- 1999-04-20 PE PE1999000331A patent/PE20000460A1/es not_active Application Discontinuation
- 1999-04-21 AR ARP990101833A patent/AR015007A1/es unknown
- 1999-04-21 AR ARP990101834A patent/AR015774A1/es unknown
-
2006
- 2006-12-08 CY CY20061101766T patent/CY1105836T1/el unknown
-
2009
- 2009-09-01 CY CY20091100911T patent/CY1109593T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69941083D1 (en) | 12,13-cyclopropan-epothilonderivate | |
ZA996185B (en) | Sulfanylsilanes. | |
ZA200005136B (en) | Dihydropyrimides. | |
PL342542A1 (en) | Substituted 2-phenyl-1-(3,4-diphydroxy-5-nitrophenyl)-ethanones | |
ZA991272B (en) | Novel thiobenzamides. | |
ZA992443B (en) | Hydroxy-methyl-hexanones. | |
DE59904407D1 (en) | Chromanderivate | |
ZA995325B (en) | Methylcyclotetradec-5-en-1-ones. | |
ZA993123B (en) | Trisresorcinyltriazines. | |
DE59900495D1 (en) | Multimetalloxidmassen | |
DE59900471D1 (en) | Inchbremseinrichtung | |
AU2964899A (en) | 2,4-dioxo-5-arylidenimino-1,3-pyrimidines | |
GB9814227D0 (en) | The worthybag | |
GB9810998D0 (en) | Antitumour 1,5-diazaanthraquinones | |
DE59905941D1 (en) | Methoximinophenylessigsäureamide | |
GB9801584D0 (en) | The maitriser | |
GB9825420D0 (en) | 755273001 | |
GB9815537D0 (en) | 2,6-Quinolines | |
GB9804598D0 (en) | The gobbler | |
HU1418U (en) | Air-reflecting, steam-closing underplate-foil | |
IL165436A0 (en) | 7,10-bis-trichlotoacetyl-10 deactylbaccatin III | |
CA84573S (en) | Sungalsses | |
AU1538P (en) | Guinevere Mandevilla sanderi | |
CA85048S (en) | Bedboard | |
ZA993690B (en) | Dam-scraper. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |